SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0000950157-08-000712
Filing Date
2008-09-23
Accepted
2008-09-23 15:40:12
Documents
2
Group Members
BRISTOL-MYERS SQUIBB BIOLOGICS COMPANY

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 5 sc13da.htm SC 13D/A 92667
2 LETTER FROM BRISTOL-MYERS SQUIBB COMPANY ex99-1.htm EX-99.1 16481
  Complete submission text file 0000950157-08-000712.txt   111327
Mailing Address 345 PARK AVE NEW YORK NY 10154
Business Address 345 PARK AVE NEW YORK NY 10154 2125464000
BRISTOL MYERS SQUIBB CO (Filed by) CIK: 0000014272 (see all company filings)

IRS No.: 220790350 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A
SIC: 2834 Pharmaceutical Preparations

Mailing Address 180 VARICK STREET - 6TH FLOOR NEW YORK NY 10014
Business Address 180 VARICK STREET - 6TH FLOOR NEW YORK NY 10014 646-638-5078
IMCLONE SYSTEMS INC (Subject) CIK: 0000765258 (see all company filings)

IRS No.: 042834797 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-42743 | Film No.: 081084515
SIC: 2836 Biological Products, (No Diagnostic Substances)